Immunomodulatory Properties of Cytokine-preconditioned Compact-bone Derived Mesenchymal Stem Cells Cultured in 2D and 3D Culture Conditions

em cells (MSCs) possess potent immunomodulatory properties and therefore represent a promising therapeutic tool for the treatment of immune-related diseases. Recently, preconditioning has been proposed as a rategy to improve the immunomodulatory activity of MSCs. In this study, we focused to inve on immunomodulatory activity of mouse compact bone-derived MSCs (CB MSCs) in 2D and 3D culture conditions. Mouse CB MSCs for the 2D condition were cultured in a andard tissue culture plate. 3D spheroid MSCs were formed by enforced composing in Nunclon Sphera 96-well U-bottom plate. MSCs in 2D and levels in lymphocytes and macrophages respectively. It was found that 3D spheroid MSCs more effectively suppressed the proliferation of T cells compared with 2D MSCs culture. Moreover, preconditioning of 3D that preconditioning with pro-compared to 2D MSC culture.

[1]  E. Mazzon,et al.  Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies , 2020, International journal of molecular sciences.

[2]  C. Loh,et al.  Human Wharton’s Jelly Mesenchymal Stem Cell-Mediated Sciatic Nerve Recovery Is Associated with the Upregulation of Regulatory T Cells , 2020, International journal of molecular sciences.

[3]  V. Ogay,et al.  GENERATION OF THREE-DIMENSIONAL SPHEROIDS FROM MOUSE MESENCHYMAL STEM CELL , 2019, Eurasian Journal of Applied Biotechnology.

[4]  S. Vella,et al.  Comparison of Immunosuppressive and Angiogenic Properties of Human Amnion-Derived Mesenchymal Stem Cells between 2D and 3D Culture Systems , 2019, Stem cells international.

[5]  G. Almeida-Porada,et al.  Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning , 2018, Front. Immunol..

[6]  Yeong-Hoon Choi,et al.  Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization , 2018, Stem Cell Research & Therapy.

[7]  D. Bueno,et al.  The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the in vivo Treatment of Immune-Related Diseases: A Systematic Review , 2018, Front. Immunol..

[8]  Li Yan,et al.  Critical Role of Tumor Necrosis Factor Signaling in Mesenchymal Stem Cell-Based Therapy for Autoimmune and Inflammatory Diseases , 2018, Front. Immunol..

[9]  Yadong Wang,et al.  A controlled release system for simultaneous delivery of three human perivascular stem cell‐derived factors for tissue repair and regeneration , 2018, Journal of tissue engineering and regenerative medicine.

[10]  H. Koo,et al.  Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-γ , 2018, EBioMedicine.

[11]  S. Goodman,et al.  Preconditioning of murine mesenchymal stem cells synergistically enhanced immunomodulation and osteogenesis , 2017, Stem Cell Research & Therapy.

[12]  M. Pozzobon,et al.  Challenges and Strategies for Improving the Regenerative Effects of Mesenchymal Stromal Cell-Based Therapies , 2017, International journal of molecular sciences.

[13]  Š. Kubínová,et al.  The therapeutic potential of three-dimensional multipotent mesenchymal stromal cell spheroids , 2017, Stem Cell Research & Therapy.

[14]  S. Grey,et al.  Immunodepletion and Hypoxia Preconditioning of Mouse Compact Bone Cells as a Novel Protocol to Isolate Highly Immunosuppressive Mesenchymal Stem Cells. , 2017, Stem cells and development.

[15]  Arezoo Mohammadipoor,et al.  Production and Administration of Therapeutic Mesenchymal Stem/Stromal Cell (MSC) Spheroids Primed in 3-D Cultures Under Xeno-free Conditions. , 2017, Journal of visualized experiments : JoVE.

[16]  V. Ogay,et al.  Preconditioning of Human Mesenchymal Stem Cells to Enhance Their Regulation of the Immune Response , 2016, Stem cells international.

[17]  D. Hommes,et al.  Intraluminal Injection of Mesenchymal Stromal Cells in Spheroids Attenuates Experimental Colitis. , 2016, Journal of Crohn's & colitis.

[18]  X. Luan,et al.  Interferon-γ and tumor necrosis factor-α promote the ability of human placenta-derived mesenchymal stromal cells to express programmed death ligand-2 and induce the differentiation of CD4(+)interleukin-10(+) and CD8(+)interleukin-10(+)Treg subsets. , 2015, Cytotherapy.

[19]  J. Kuiper,et al.  Mesenchymal Stem Cells Reduce Murine Atherosclerosis Development , 2015, Scientific Reports.

[20]  Todd C McDevitt,et al.  Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion. , 2014, Cytotherapy.

[21]  Jacques Galipeau,et al.  Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  J. Karp,et al.  Mesenchymal stem cell therapy: Two steps forward, one step back. , 2010, Trends in molecular medicine.

[23]  Yi Zhang,et al.  A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone , 2010, Nature Protocols.

[24]  R. Zhao,et al.  Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell Stem Cell.

[25]  D. Prockop,et al.  Methods and protocols. Preface. , 2008, Methods in molecular biology.

[26]  S. Kain,et al.  Growth of wildtype and mutant E. coli strains in minimal media for optimal production of nucleic acids for preparing labeled nucleotides , 2010, Applied Microbiology and Biotechnology.